News

Eligible clinicians and entities participating in state Medicaid payment arrangements may ask the Centers for Medicare & Medicaid Services through Nov. 1 to determine whether the arrangement qualifies as an advanced alternative payment model for performance year 2019.

The Centers for Medicare & Medicaid Services today announced updated tools to help Medicare beneficiaries compare coverage options and estimate costs during open enrollment, part of a multi-year initiative to modernize how beneficiaries get Medicare information.

Today, new ICD-10-CM codes take effect so clinicians can better classify a diagnosis for patients who are victims of human trafficking.

The House of Representatives today passed by a vote of 393-8 the final version of the Opioid Crisis Response Act (H.R. 6).

The Centers for Medicare & Medicaid Services yesterday released frequently asked questions on new requirements for hospitals to publicly post their charges in a machine-readable format on an annual basis

The Centers for Medicare & Medicaid Services today issued a proposed rule that would revise regulations setting forth the appeals process that Medicare beneficiaries, providers and suppliers must follow in order to appeal adverse determinations regarding claims for benefits under Medicare Parts A and B and prescription drug coverage under Part D.

The Centers for Medicare & Medicaid Services should enhance its oversight of Medicare Advantage organization contracts and address persistent problems related to inappropriate denial of services and payment, the Department of Health and Human Services’ Office of Inspector General said in a report yesterday.

The Centers for Medicare & Medicaid Services today released premium and cost infor

Insurers have proposed to cut premiums for 2019 benchmark plans on the federal health insurance exchange by 2 percent nationally, Health and Human Services Secretary Alex Azar announced yesterday.

The AHA Physician Leadership Experience, Nov. 1-3 in Colorado Springs, helps participants create a new professional strategy to offset the demands of the 24/7/365 health care environment.

The opioid epidemic’s grip on our communities continues to be a major challenge. At the same time, we also see progress in addressing the problem. 

The House of Representatives last night voted 361-61 to pass legislation to provide $178.1 billion in discretionary funding for the departments of Defense, Labor, Health and Human Services, and Education in fiscal year 2019 and extend current funding levels for other federal programs until Dec. 7.

An estimated 92 percent of hospital workers report receiving a flu vaccine for the 2017-18 flu season, compared with 75 percent of ambulatory care workers and 67 percent of long-term care workers.

The Department of Health and Human Services today awarded Hospital Preparedness Program grants to Nebraska Medicine in Omaha and Massachusetts General Hospital in Boston to conduct pilot projects to demonstrate the potential effectiveness and viability of a Regional Disaster Health Response System.

The Health Resources and Services Administration this week awarded $12.4 million to help states expand access to behavioral health care for children and pregnant women.

The Substance Abuse and Mental Health Services Administration this week awarded American Indian and Alaska Native tribes $50 million in grants to combat opioid overdoses.

The National Academies of Sciences, Engineering, and Medicine Board on Population Health and Public Health Practice will host a workshop Oct. 17-18 in Washington, D.C., on health system interventions to prevent firearm injury and death.

Bipartisan leaders from committees of jurisdiction in the House and Senate yesterday reached agreement on the final provisions of the Opioid Crisis Response Act.

The Senate Health, Education, Labor and Pensions Subcommittee on Primary Health and Retirement Security yesterday held a hearing to examine health care experiences and costs in rural America.

The House of Representatives yesterday passed two bills that would prohibit health plans from restricting a pharmacist’s ability to inform enrollees when a drug would cost less without using their insurance.